Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized comparative study of topical ivermectin 1% versus eyelid wipes for blepharitis with Demodex
MOH_2018-03-26_002282Phase 4Not yet recruiting
- Sponsor
- פרופ' איגור קיזרמן
- Start
- Feb 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of ivermectin in blepharitis and demodicidosis (2 arms), sponsored by פרופ' איגור קיזרמן. Planned start Feb 2018; status: not yet recruiting.
02
Drugs
ivermectin
03
Conditions
blepharitisdemodicidosis
Beyond the preview
Go deeper on MOH_2018-03-26_002282.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2018-03-26_002282.